Skip to main content

Table 2 In-hospital outcomes by acute kidney injury and renal replacement therapy status

From: Long-term outcomes in patients who received veno-venous extracorporeal membrane oxygenation and renal replacement therapy: a retrospective cohort study

Characteristica

Overall, N = 300

AKI, RRT, N = 178

AKI, no RRT, N = 52

No AKI, N = 70

In-hospital mortality

65 (21.7%)

48 (27.0%)

6 (11.5%)

11 (15.7%)

ICU length of stay (days)

21 (14, 32)

24 (16, 38)

17 (11, 26)

19 (12, 32)

Hospital length of stay (days)

26 (17, 45)

27 (18, 47)

24 (15, 35)

28 (16, 46)

ECMO duration (days)

9 (6, 16)

10 (7, 16)

8 (6, 14)

8 (6, 18)

ECMO weaning

240 (80.0%)

133 (74.7%)

47 (90.4%)

60 (85.7%)

MV duration (days)

16 (10, 26)

18 (12, 29)

14 (9, 18)

12 (7, 25)

Sepsis

157 (52.3%)

102 (57.3%)

24 (46.2%)

31 (44.3%)

Bleeding

66 (22.0%)

49 (27.5%)

6 (11.5%)

11 (15.7%)

Stroke

42 (14.0%)

7 (13.5%)

30 (16.9%)

5 (7.1%)

Thrombosis

84 (28.0%)

53 (29.8%)

13 (25.0%)

18 (25.7%)

Total number of packed red blood cell units during ICU admission (n = 256)b

6 (3, 12)

9 (5, 17)

3 (2, 5)

4 (2, 8)

Total number of cryoprecipitate/FFP units during ICU admission (n = 86)b

6 (4, 13)

8 (4, 15)

2 (2, 6)

6 (4, 7)

Total number of platelets during ICU admission (n = 127)b

5 (3, 10)

5 (4, 11)

1 (1, 2)

4 (2, 6)

  1. AKI acute kidney injury, ECMO extracorporeal membrane oxygenation, FFP fresh frozen plasma, ICU intensive care unit, MV mechanical ventilation, RRT renal replacement therapy
  2. aStatistics presented: n (%), median (interquartile range)
  3. bExcluded those who did not receive blood products during admission